Evidence map›Paper›PMID 22990890›Full record

ReviewNature immunology2012

From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.

Jacques Banchereau, Virginia Pascual, Anne O'Garra

Abstract readReview
In one paragraph

Review in Nature immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 189 papers.

0numbers the graph read from it
0cells of the map it votes in
189citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

189 citing papers in PubMed.

  1. Comparison of crevicular fluid cytokine levels after the application of surface sealants : A randomized trial.Journal of orofacial orthopedics = Fortschritte der Kieferorthopadie : Organ/official journal Deutsche Gesellschaft fur Kieferorthopadie · 2019
    Trial
  2. Review
  3. Decoding TNF receptor superfamily control of CD4Cell communication and signaling : CCS · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Deep insight into cytokine storm: from pathogenesis to treatment.Signal transduction and targeted therapy · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Circulating MicroRNAs and Cytokines Associated with Celiac Disease.Middle East journal of digestive diseases · 2024
    Article
  16. Article
  17. Article
  18. The non-pathogenic protozoonFrontiers in immunology · 2024
    Article
  19. Article
  20. Article

129 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jacques BanchereauBaylor Institute for Immunology Research, Dallas, Texas, USA. jacques.banchereau@gmail.com
Virginia Pascual
Anne O'Garra

Funding

Scientific CoreU19AI082715 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLANKENSHIP, DEREK · 2009 to 2018
$6.4M
Use of Microarrays to Understand Systemic ArthritisR01AR050770 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2003 to 2012
$3.1M
Medical Research Council MC_U117565642Medical Research Council U117565642NIAID NIH HHS U19 AI082715NIAMS NIH HHS R01 AR050770PHS HHS AIO82715PHS HHS ARO50770-02
6 · The paper itself

Abstract

Feedback regulatory circuits provided by regulatory T cells (T(reg) cells) and suppressive cytokines are an intrinsic part of the immune system, along with effector functions. Here we discuss some of the regulatory cytokines that have evolved to permit tolerance to components of self as well as the eradication of pathogens with minimal collateral damage to the host. Interleukin 2 (IL-2), IL-10 and transforming growth factor-β (TGF-β) are well characterized, whereas IL-27, IL-35 and IL-37 represent newcomers to the spectrum of anti-inflammatory cytokines. We also emphasize how information accumulated through in vitro as well as in vivo studies of genetically engineered mice can help in the understanding and treatment of human diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsCytokinesHumansInflammationInflammation MediatorsInterleukin-1Interleukin-10Interleukin-17Interleukin-2InterleukinsMiceT-Lymphocytes, RegulatoryTransforming Growth Factor betaAnti-Inflammatory AgentsCytokinesIL37 protein, humanInflammation MediatorsInterleukin-1Interleukin-10Interleukin-17Interleukin-2interleukin-35, humanInterleukinsTransforming Growth Factor beta

Identifiers

PMID22990890
PMCPMC3609707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.